Why participate?
Present the methodology and publicly available online tools for in silico immunogenicity prediction
Training Context:
Immunogenicity prediction is a central concern for pharmaceutical companies. The stakes are high—not only for patient safety and the efficacy of the biopharmaceutical, but also for the long-term success of the sponsoring company. While many in silico prediction tools developed by commercial entities are available on the market, this course focuses on exploring the underlying methodology using freely accessible tools.
You will conduct an immunogenicity assessment of a set of therapeutic antibodies using IEDB and IMGT tools. Group work will be followed by presentations and guided correction.
R&D professionals, project managers, researchers, engineers, and technicians
Basic knowledge of biochemistry, biotechnology, or immunology, or completion of the course “Immunogenicity of therapeutic proteins: mechanisms, prediction, and risk management”
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
Participant satisfaction rate :
Return rate of satisfaction questionnaires :
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
